Loading company…
Schlieren, Switzerland provider of ex vivo drug testing that analyzes patients' living cancer cells to guide oncology treatment.
Founded in 2024 and based in Schlieren, Switzerland, Prevision Medicine AG provides ex vivo drug testing through its PrevisionOne platform. The platform analyzes patients' living cancer cells against drugs and drug combinations and delivers clinical reports to help oncologists select treatment options.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in